Reports on the Status of Postmarketing Study Commitments — Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 16, 2006
February 1, 2021
ec0f0699-da15-4639-8504-483baf9b5ea9
Related Documents
Chronic Cutaneous Ulcer and Burn Wounds -- Developing Products for Treatment
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients
Guidance DocumentMay 19, 2005Center for Drug Evaluation and Research
S8 Immunotoxicity Studies for Human Pharmaceuticals
Guidance DocumentApril 12, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.